Name of applicant: |
Hikma Pharmaceuticals PLC |
Name of scheme: |
Hikma Pharmaceuticals PLC 2004 Stock Option Plan ("SOP") & Hikma Pharmaceuticals PLC 2005 Long-Term Incentive Plan ("LTIP") & Hikma Pharmaceuticals PLC 2009 Management Incentive Plan ("MIP") & Hikma Pharmaceuticals PLC 2014 Executive Incentive Plan ("EIP") |
Period of return |
From: |
1 October 2016 |
To: |
31 March 2017 |
Balance of unallotted securities under scheme(s) from previous return: |
SOP: 792,700 ordinary shares of 10 pence LTIP: 305,031 ordinary shares of 10 pence MIP: 111,007 ordinary shares of 10 pence EIP: 0 ordinary shares of 10 pence |
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
SOP: 0 ordinary shares of 10 pence LTIP: 121,000 ordinary shares of 10 pence MIP: 200,000 ordinary shares of 10 pence EIP: 379,000 ordinary shares of 10 pence |
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
SOP: 0 ordinary shares of 10 pence LTIP: 35,940 ordinary shares of 10 pence MIP: 393 ordinary shares of 10 pence EIP: 14,394 ordinary shares of 10 pence |
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
SOP: 792,700 ordinary shares of 10 pence LTIP: 390,091 ordinary shares of 10 pence MIP: 310,614 ordinary shares of 10 pence EIP: 364,606 ordinary shares of 10 pence |
|
|
|
|
|